Gold has a perfect track record as a hedge against inflation -- for as long as inflation has been measured. We explain why.
Texas Bills To Require Psychoactive Drug Study Head To Governor’s Desk
In the final days of Texas’s legislative session, lawmakers sent bills to the governor’s desk that would require a study into the therapeutic potential of certain psychedelics for military veterans.
New Analysis Shows Tax Revenue From Cannabis In The Billions
States that have legalized adult-use marijuana sales have seen billions of dollars in fresh tax revenue from cannabis.
Gold price holding on to $1,900
Gold prices are holding above $1,900 an ounce even as the U.S. economy sees further growth in the U.S. manufacturing sector.
Gold, silver see price gains on bullish outside markets
Gold and silver prices are modestly higher in early morning U.S. trading Tuesday, with gold scoring a five-month high.
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights
Novamind's clinic revenues jumped 43% quarter-over-quarter, to CAD$1.85 million. Projecting a 225% increase in clinic visits year-over-year.
Psychedelic Drug Stocks: A BIG Healthcare Footprint At A SMALL Price
The psychedelic drug industry already has a large footprint in healthcare. And it is growing in literally every direction.
This is why psilocybin may be able to help millions
It may only be a matter of time before psychedelics become a go-to treatment for millions suffering with some sort of mental illness.
Another bill clears to study psychoactive drugs to treat vets with PTSD
The Texas Legislature has approved a study that will look at using psilocybin as a treatment for veterans struggling with Post-Traumatic Stress Disorder.
Gold price steady as U.S. annual core PCE beats expectations
Gold is largely unchanged after the U.S. annual core PCE price index came in above expectations in April, advancing 3.1% versus the expected 1.4%.
Is gold set to tear even higher?
Bullion is one of the best-performing commodities this month, erasing almost all of this year’s losses. Investors have been lured back by gold’s appeal.
Health Official Touts Psilocybin's’ Therapeutic Benefits
A top U.S. health official on Wednesday touted the therapeutic potential of psychedelics like psilocybin and MDMA.